Yue Jiang

Company: Shape Therapeutics

Job title: Director, head of ML

Seminars:

Leveraging AI & RNA Technology to Design Programmable RNA Medicines 2:30 pm

Harnessing high throughput screening to enable accurate modeling of ADAR-mediated RNA editing in vitro Utilizing generative modeling to allow de novo guide RNA designs for RNA editing Spotlighting transfer learning to leverage smaller datasets to optimize guide RNA designs for in cell performance  Read more

day: Conference Day Two